
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Eosinophil-to-Lymphocyte Ratio Acts as an Indicator for Improvement of Clinical Signs and Itch by Upadacitinib Treatment in Atopic Dermatitis
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 6, pp. 2201-2201
Open Access | Times Cited: 23
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 6, pp. 2201-2201
Open Access | Times Cited: 23
Showing 23 citing articles:
Predictive factors for responders to upadacitinib treatment in patients with atopic dermatitis
Teppei Hagino, Mai Yoshida, Risa Hamada, et al.
Journal of Dermatological Treatment (2024) Vol. 35, Iss. 1
Open Access | Times Cited: 11
Teppei Hagino, Mai Yoshida, Risa Hamada, et al.
Journal of Dermatological Treatment (2024) Vol. 35, Iss. 1
Open Access | Times Cited: 11
Effectiveness and safety of deucravacitinib treatment for moderate-to-severe psoriasis in real-world clinical practice in Japan
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, et al.
Journal of Dermatological Treatment (2024) Vol. 35, Iss. 1
Open Access | Times Cited: 10
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, et al.
Journal of Dermatological Treatment (2024) Vol. 35, Iss. 1
Open Access | Times Cited: 10
Total eosinophil count as a biomarker for therapeutic effects of upadacitinib in atopic dermatitis over 48 weeks
Teppei Hagino, Risa Hamada, Mai Yoshida, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Teppei Hagino, Risa Hamada, Mai Yoshida, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Effects of Tralokinumab on Clinical and Laboratory Indexes in Atopic Dermatitis: A 24-Week Real-World Study
Teppei Hagino, M Onda, Hidehisa Saeki, et al.
Dermatitis (2024)
Closed Access | Times Cited: 8
Teppei Hagino, M Onda, Hidehisa Saeki, et al.
Dermatitis (2024)
Closed Access | Times Cited: 8
The Association of Inflammatory Indexes Derived from Peripheral Blood Cell Count and Clinical Signs with Response to Treatment with Dupilumab in Pediatric Patients with Moderate-to-Severe Atopic Dermatitis
Lingzhao Zhang, Jiangshan Pi, Jinsong Wang, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 271-282
Open Access | Times Cited: 1
Lingzhao Zhang, Jiangshan Pi, Jinsong Wang, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 271-282
Open Access | Times Cited: 1
Therapeutic effectiveness of upadacitinib on individual types of rash in Japanese patients with moderate‐to‐severe atopic dermatitis
Teppei Hagino, Mai Yoshida, Risa Hamada, et al.
The Journal of Dermatology (2023) Vol. 50, Iss. 12, pp. 1576-1584
Open Access | Times Cited: 15
Teppei Hagino, Mai Yoshida, Risa Hamada, et al.
The Journal of Dermatology (2023) Vol. 50, Iss. 12, pp. 1576-1584
Open Access | Times Cited: 15
Effectiveness of switching from baricitinib 4 mg to upadacitinib 30 mg in patients with moderate-to-severe atopic dermatitis: a real-world clinical practice in Japan
Teppei Hagino, Mai Yoshida, Risa Hamada, et al.
Journal of Dermatological Treatment (2023) Vol. 34, Iss. 1
Open Access | Times Cited: 14
Teppei Hagino, Mai Yoshida, Risa Hamada, et al.
Journal of Dermatological Treatment (2023) Vol. 34, Iss. 1
Open Access | Times Cited: 14
Background factors predicting the occurrence of herpes zoster in atopic dermatitis patients treated with upadacitinib
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, et al.
The Journal of Dermatology (2023) Vol. 50, Iss. 10, pp. 1301-1312
Closed Access | Times Cited: 13
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, et al.
The Journal of Dermatology (2023) Vol. 50, Iss. 10, pp. 1301-1312
Closed Access | Times Cited: 13
Increased Neutrophil–Lymphocyte Ratio and Platelet–Lymphocyte Ratio in Chronic and Severe Urticaria
Sarah Weissmann, Nitzan Burrack, Inbal Golan‐Tripto, et al.
Acta Dermato Venereologica (2024) Vol. 104, pp. adv23932-adv23932
Open Access | Times Cited: 4
Sarah Weissmann, Nitzan Burrack, Inbal Golan‐Tripto, et al.
Acta Dermato Venereologica (2024) Vol. 104, pp. adv23932-adv23932
Open Access | Times Cited: 4
Predictive Factors for Poor Responders to Tralokinumab in Moderate-to-Severe Atopic Dermatitis: A Real-World Analysis
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, et al.
Dermatitis (2025)
Closed Access
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, et al.
Dermatitis (2025)
Closed Access
Response to Comments on The Association of Inflammatory Indexes Derived From Peripheral Blood Cell Count and Clinical Signs with Response to Treatment with Dupilumab in Pediatric Patients with Moderate-to-Severe Atopic Dermatitis [Response to Letter]
Lingzhao Zhang, Jiangshan Pi, Jinsong Wang, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 3551-3553
Open Access
Lingzhao Zhang, Jiangshan Pi, Jinsong Wang, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 3551-3553
Open Access
Hematological Markers in Children and Adults with Atopic Dermatitis: A Retrospective Cohort Study
Sarah Weissmann, Amit Shira Babyev, Michal Gordon, et al.
Dermatology (2024) Vol. 240, Iss. 4, pp. 597-605
Closed Access | Times Cited: 3
Sarah Weissmann, Amit Shira Babyev, Michal Gordon, et al.
Dermatology (2024) Vol. 240, Iss. 4, pp. 597-605
Closed Access | Times Cited: 3
Predictive Factors for Long-Term High Responders to Upadacitinib Treatment in Patients with Atopic Dermatitis
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, et al.
Dermatitis (2024)
Closed Access | Times Cited: 3
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, et al.
Dermatitis (2024)
Closed Access | Times Cited: 3
Dupilumab Treatment Efficacy and Impact on Clinical Scores, Serum Biomarkers, and Itch in Adult Patients with Atopic Dermatitis: A Retrospective Analysis
Mariateresa Rossi, Luca Bettolini, Grazia Linda Artelli, et al.
Journal of Asthma and Allergy (2023) Vol. Volume 16, pp. 1233-1240
Open Access | Times Cited: 6
Mariateresa Rossi, Luca Bettolini, Grazia Linda Artelli, et al.
Journal of Asthma and Allergy (2023) Vol. Volume 16, pp. 1233-1240
Open Access | Times Cited: 6
Early itch relief with upadacitinib predicts later skin clearance in Atopic dermatitis
Teppei Hagino, Mai Yoshida, Risa Hamada, et al.
Journal of Dermatological Treatment (2023) Vol. 35, Iss. 1
Open Access | Times Cited: 6
Teppei Hagino, Mai Yoshida, Risa Hamada, et al.
Journal of Dermatological Treatment (2023) Vol. 35, Iss. 1
Open Access | Times Cited: 6
Eosinophil-Count-Derived Inflammatory Markers and Psoriasis Severity: Exploring the Link
Oana Mirela Tiucă, Silviu Horia Morariu, Claudia Raluca Mariean, et al.
Dermato (2024) Vol. 4, Iss. 2, pp. 25-36
Open Access | Times Cited: 1
Oana Mirela Tiucă, Silviu Horia Morariu, Claudia Raluca Mariean, et al.
Dermato (2024) Vol. 4, Iss. 2, pp. 25-36
Open Access | Times Cited: 1
Predictive Factors for Primary and Secondary Nonresponders to Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis: A Real-World Study
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, et al.
Dermatitis (2024)
Closed Access | Times Cited: 1
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, et al.
Dermatitis (2024)
Closed Access | Times Cited: 1
Identification of Early and Late Responders to Anti-IL-13 Antibody Tralokinumab in Atopic Dermatitis: A Real-World Japanese Study
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, et al.
Dermatitis (2024)
Closed Access | Times Cited: 1
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, et al.
Dermatitis (2024)
Closed Access | Times Cited: 1
Eosinophil–Basophil/Lymphocyte (EB/LR) and Eosinophil–Basophil–Platelet/Lymphocyte (EBP/LR) Ratios Could Serve as Useful Additional Markers for Assessing the Severity of Wasp Allergic Reactions
Weronika Urbańska, Łukasz Szymański, Aneta Lewicka, et al.
Cells (2024) Vol. 13, Iss. 21, pp. 1786-1786
Open Access
Weronika Urbańska, Łukasz Szymański, Aneta Lewicka, et al.
Cells (2024) Vol. 13, Iss. 21, pp. 1786-1786
Open Access
Eosinophil-to-Lymphocyte Ratio and Eosinophil Count as New Predictive Markers for Osteoarthritis
Jingkai Di, Liying Song, Y Liu, et al.
Journal of Pain Research (2024) Vol. Volume 17, pp. 3803-3815
Open Access
Jingkai Di, Liying Song, Y Liu, et al.
Journal of Pain Research (2024) Vol. Volume 17, pp. 3803-3815
Open Access
Hotspots and development trends of gut microbiota in atopic dermatitis: A bibliometric analysis from 1988 to 2024
Fang Liu, Haipeng Zhang, Lina Fan, et al.
Medicine (2024) Vol. 103, Iss. 50, pp. e40931-e40931
Open Access
Fang Liu, Haipeng Zhang, Lina Fan, et al.
Medicine (2024) Vol. 103, Iss. 50, pp. e40931-e40931
Open Access
Association of Inflammatory Indicators and Clinical Signs and Itch in Atopic Dermatitis Patients Treated with Simiao Pill Combined with Halomethasone Cream
Jun Cao, Hui Liu, Xiaojie Ding
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 3643-3653
Open Access
Jun Cao, Hui Liu, Xiaojie Ding
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 3643-3653
Open Access
Effects of TMEM232 variant on blood lymphocyte counts in relation to incidence of infant atopic dermatitis
Eun-A Choi, Hee-Soo Han, Guemkyung Nah, et al.
Research Square (Research Square) (2023)
Open Access
Eun-A Choi, Hee-Soo Han, Guemkyung Nah, et al.
Research Square (Research Square) (2023)
Open Access